1. News & Events
  2. Blog

Blog

TCS and Vanderbilt University Medical Center partner to advance healthcare and life sciences research

Tata Consultancy Services (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, announced a new partnership with Vanderbilt University Medical Center (VUMC) to drive innovation in the healthcare and life sciences fields.

VEN: Investor Perspectives Panel Session

Vanderbilt Entrepreneurial Network Presents Investor Perspective Panel Session

Get ready for a special panel session this week featuring 4 real-world investors at all stages of the investment food chain on Thursday 11/4 at 5:30pm in 136 Featheringill Hall! Here’s a preview of what’s ahead: Week 7 Preview (Nov 4th): Investor Perspectives Want to know how investors think, and how the investment food chain works? Come on down! Panelists include:

Two Vanderbilt technologies earned patent protection in October

Two new Vanderbilt technologies earned patent protection in Octoberr.

 

HERMES Medical Solutions and Vanderbilt University announce exclusive license and commercialization agreement

HERMES Medical Solutions (HERMES) by Sofia Bertling COO and Vanderbilt University (Vanderbilt) by Professor Michael Stabin announced today the signature of an exclusive license and commercialization agreement for the new dosimetry application OLINDA / EXM® to be distributed by HERMES.

Five Vanderbilt technologies earned patent protection in September

Five Vanderbilt technologies earned patent protection in September.

9,140,705   Tumor suppressor killin

PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

Two Vanderbilt technologies, PinPtr (high-precision, low-cost GPS cloud service) and VenoStent (stent to prevent intimal hyperplasia) have been awarded the coveted National Science Foundation Accelerating Innovation Research - Technology Translation (AIR-TT) grant of approximately $200,000 (each). PinPtr is led by Dr. Akos Ledeczi, Associate Professor and Senior Research Scientist and Dr.

Three Vanderbilt technologies earned patent protection in August

Three Vanderbilt technologies earned patent protection in August.

9,108,963      Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions,

La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

A new research alliance between Dr. Charles Hong, associate Professor of Cardiovascular Medicine, Pharmacology, and Cell and Developmental Biology, Dr. Craig Lindsley, Professor of Pharmacology and Chemistry, and Dr. Corey Hopkins, Research Assistant Professor of Pharmacology and Chemistry, and La Jolla Pharmaceutical Company was announced. The goal of this collaboration is to research and develop small-molecule BMP type-I receptor inhibitors designed to aid in treatment of rare genetic disorders. Below is the full news release:

Three Vanderbilt technologies earned patent protection in July

Three Vanderbilt technologies earned patent protection in July. All three are new technologies from the Vanderbilt Center for Neuroscience Drug Discovery.

9,090,632             Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors

CTTC helps launch 16 Startups

At least 16 startups were launched over the past 24 months with the help of CTTC. All of these startups had Vanderbilt University intellectual property licenses aboard.

See the full list here: http://www.venturenashville.com/vanderbilt-university-commercialization-...